Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerem Wainer-Katsir

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|July 14, 2020
BIRD: identifying cell doublets via biallelic expression from single cellsKerem Wainer-Katsir, Michal Linial
BMC Genomics|March 16, 2019
Human genes escaping X-inactivation revealed by single cell expression dataKerem Wainer Katsir, Michal Linial
Fertility and Sterility|March 23, 2015
Extended fertility and longevity: the genetic and epigenetic linkKerem Wainer-Katsir, James Y Zou, Michal Linial
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Frontiers in Oncology|March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cellsHila Fishman, Hila M Ene, Einav Zeevi, et al.
Cell Death & Disease|March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
Cell Death Discovery|July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.
International Journal of Cancer|February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxelTal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|July 14, 2020
BIRD: identifying cell doublets via biallelic expression from single cellsKerem Wainer-Katsir, Michal Linial
BMC Genomics|March 16, 2019
Human genes escaping X-inactivation revealed by single cell expression dataKerem Wainer Katsir, Michal Linial
Fertility and Sterility|March 23, 2015
Extended fertility and longevity: the genetic and epigenetic linkKerem Wainer-Katsir, James Y Zou, Michal Linial
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Frontiers in Oncology|March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cellsHila Fishman, Hila M Ene, Einav Zeevi, et al.
Cell Death & Disease|March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
Cell Death Discovery|July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.
International Journal of Cancer|February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxelTal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Pageof 1